ANI Pharmaceuticals eye implant trial meets both primary endpoints
Go back to ANI Pharmaceuticals eye implant trial meets both primary endpoints| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 78.53 +0.92 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $77.61 | 52 Week High | $70.92 | |||
| Open | $77.15 | 52 Week Low | $26.80 | |||
| Day High | $78.96 | P/E | N/A | |||
| Day Low | $76.43 | EPS | $-0.96 | |||
| Volume | 245,690 | |||||
